4.4 Article

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

Related references

Note: Only part of the references are listed.
Article Oncology

Association of Low-Grade Glioma Diagnosis and Management Approach with Mental Health Disorders: A MarketScan Analysis 2005-2014

Debarati Bhanja et al.

Summary: Low-grade gliomas (LGGs) account for 13-16% of glial tumors. The incidence, prevalence, and risk factors of mental health disorders (MHD) in LGG patients were investigated in this retrospective cohort study. Among 20,432 LGG patients, 60.9% had MHD, with 16.9% of patients developing new-onset MHD within 12 months of LGG diagnosis. Risk factors included female gender, ages 35-54, presence of seizures, and first-line surgical treatment. Proactive surveillance and counseling for MHDs are recommended, as well as consideration of the impact of surgery on brain networks affecting mood.

CANCERS (2022)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Review Clinical Neurology

Current State of Health Economic Analyses for Low-Grade Glioma Management: A Systematic Review

Kyle Tuohy et al.

Summary: This study evaluated the economic evaluations for low-grade glioma (LGG) management and found that although the number of economic evaluation studies is limited, these studies were well designed and considered to be cost-effective interventions. However, due to heterogeneity in the interventions assessed, pooled analysis was not possible.

WORLD NEUROSURGERY (2021)

Article Oncology

Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence

Karanbir Brar et al.

FRONTIERS IN ONCOLOGY (2020)

Review Clinical Neurology

Management of low-grade glioma: a systematic review and meta-analysis

Timothy J. Brown et al.

NEURO-ONCOLOGY PRACTICE (2019)

Review Medicine, General & Internal

Biopsy versus resection for the management of low-grade gliomas

Bowen Jiang et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Oncology

Surgical resection versus watchful waiting in low-grade gliomas

A. S. Jakola et al.

ANNALS OF ONCOLOGY (2017)

Article Health Care Sciences & Services

Drivers of hospitalization cost after craniotomy for tumor resection: creation and validation of a predictive model

Symeon Missios et al.

BMC HEALTH SERVICES RESEARCH (2015)

Article Clinical Neurology

Complications Following Stereotactic Needle Biopsy of Intracranial Tumors

Hani Malone et al.

WORLD NEUROSURGERY (2015)

Review Clinical Neurology

The challenge to remove diffuse low-grade gliomas while preserving brain functions

Hugues Duffau

ACTA NEUROCHIRURGICA (2012)

Article Medicine, General & Internal

Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas

Asgeir S. Jakola et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Mathematics, Interdisciplinary Applications

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

Peter C. Austin

MULTIVARIATE BEHAVIORAL RESEARCH (2011)

Article Clinical Neurology

Dynamic history of low-grade gliomas before and after temozolomide treatment

Damien Ricard et al.

ANNALS OF NEUROLOGY (2007)

Article Clinical Neurology

Continuous growth of mean tumor diameter in a subset of grade II gliomas

E Mandonnet et al.

ANNALS OF NEUROLOGY (2003)

Article Oncology

Prognostic factors for survival in adult patients with cerebral low-grade glioma

F Pignatti et al.

JOURNAL OF CLINICAL ONCOLOGY (2002)